215 related articles for article (PubMed ID: 19419768)
81. X-linked agammaglobulinemia: Twenty years of single-center experience from North West India.
Singh S; Rawat A; Suri D; Gupta A; Garg R; Saikia B; Minz RW; Sehgal S; Chan KW; Lau YL; Kamae C; Honma K; Nakagawa N; Imai K; Nonoyama S; Oshima K; Mitsuiki N; Ohara O
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):405-411. PubMed ID: 27593100
[TBL] [Abstract][Full Text] [Related]
82. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females.
Futatani T; Watanabe C; Baba Y; Tsukada S; Ochs HD
Br J Haematol; 2001 Jul; 114(1):141-9. PubMed ID: 11472359
[TBL] [Abstract][Full Text] [Related]
83. Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency.
Mirsafian H; Ripen AM; Leong WM; Chear CT; Bin Mohamad S; Merican AF
Sci Rep; 2017 Jul; 7(1):6836. PubMed ID: 28754963
[TBL] [Abstract][Full Text] [Related]
84. Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model.
Bestas B; Moreno PM; Blomberg KE; Mohammad DK; Saleh AF; Sutlu T; Nordin JZ; Guterstam P; Gustafsson MO; Kharazi S; Piątosa B; Roberts TC; Behlke MA; Wood MJ; Gait MJ; Lundin KE; El Andaloussi S; Månsson R; Berglöf A; Wengel J; Smith CI
J Clin Invest; 2014 Sep; 124(9):4067-81. PubMed ID: 25105368
[TBL] [Abstract][Full Text] [Related]
85. De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma.
Lin MT; Chien YH; Shyur SD; Huang LH; Chiang YC; Wen DC; Liang PH; Yang HC
Ann Allergy Asthma Immunol; 2006 May; 96(5):744-8. PubMed ID: 16729790
[TBL] [Abstract][Full Text] [Related]
86. Maternal germinal mosaicism of X-linked agammaglobulinemia.
Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N
Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495
[TBL] [Abstract][Full Text] [Related]
87. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
Hyvönen M; Saraste M
EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
[TBL] [Abstract][Full Text] [Related]
88. Familial hemophagocytic lymphohistiocytosis in two brothers with X-linked agammaglobulinemia.
Schultz KA; Neglia JP; Smith AR; Ochs HD; Torgerson TR; Kumar A
Pediatr Blood Cancer; 2008 Aug; 51(2):293-5. PubMed ID: 18421721
[TBL] [Abstract][Full Text] [Related]
89. Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function.
Gagliardi MC; Finocchi A; Orlandi P; Cursi L; Cancrini C; Moschese V; Miyawaki T; Rossi P
Clin Exp Immunol; 2003 Jul; 133(1):115-22. PubMed ID: 12823285
[TBL] [Abstract][Full Text] [Related]
90. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
Mattsson PT; Vihinen M; Smith CI
Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
[TBL] [Abstract][Full Text] [Related]
91. Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X-linked agammaglobulinemia (XLA).
Velickovic M; Prasad ML; Weston SA; Benson EM
Hum Mutat; 2004 Apr; 23(4):398-9. PubMed ID: 15024743
[TBL] [Abstract][Full Text] [Related]
92. Impact of amino acid substitution in the kinase domain of Bruton tyrosine kinase and its association with X-linked agammaglobulinemia.
Mohammad T; Amir M; Prasad K; Batra S; Kumar V; Hussain A; Rehman MT; AlAjmi MF; Hassan MI
Int J Biol Macromol; 2020 Dec; 164():2399-2408. PubMed ID: 32784026
[TBL] [Abstract][Full Text] [Related]
93. Novel mutations in hyper-IgM syndrome type 2 and X-linked agammaglobulinemia detected in three patients with primary immunodeficiency disease.
Chen X; Liu F; Yuan L; Zhang M; Chen K; Wu Y
Mol Genet Genomic Med; 2021 Jan; 9(1):e1552. PubMed ID: 33377626
[TBL] [Abstract][Full Text] [Related]
94. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Iwata T; Kinnon C; Kwan SP; Ochs HD; Vorechovský I; Smith CI
Nucleic Acids Res; 1996 Jan; 24(1):160-5. PubMed ID: 8594569
[TBL] [Abstract][Full Text] [Related]
95. Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus.
Luk ADW; Ni K; Wu Y; Lam KT; Chan KW; Lee PP; Tu W; Mao H; Lau YL
Front Immunol; 2018; 9():1826. PubMed ID: 30147693
[TBL] [Abstract][Full Text] [Related]
96. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
[TBL] [Abstract][Full Text] [Related]
97. Clinical characteristics and molecular analysis of 21 Chinese children with congenital agammaglobulinemia.
Zhang ZY; Zhao XD; Jiang LP; Liu EM; Wang M; Yu J; Liu P; Yang XQ
Scand J Immunol; 2010 Nov; 72(5):454-9. PubMed ID: 21039741
[TBL] [Abstract][Full Text] [Related]
98. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
[TBL] [Abstract][Full Text] [Related]
99. Clinical and mutational features of X-linked agammaglobulinemia in Mexico.
García-García E; Staines-Boone AT; Vargas-Hernández A; González-Serrano ME; Carrillo-Tapia E; Mogica-Martínez D; Berrón-Ruíz L; Segura-Mendez NH; Espinosa-Rosales FJ; Yamazaki-Nakashimada MA; Santos-Argumedo L; López-Herrera G
Clin Immunol; 2016 Apr; 165():38-44. PubMed ID: 26960951
[TBL] [Abstract][Full Text] [Related]
100. Identification of novel non-pathogenic mutation in SH3 domain of Btk in an XLA patient.
Pérez de Diego R; Bravo J; Allende LM; López-Granados E; Rivera J; Ferreira A; Fontán G; García Rodríguez MC
Mol Immunol; 2008 Jan; 45(1):301-3. PubMed ID: 17707910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
